AdaptVac 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Trials    News 
1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABNCoV2 / University of Copenhagen, Leiden University Medical Center, Bavarian Nordic, AdaptVac, ExpreS2ion, University of Tuebingen
NCT05077267: ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Recruiting
2
210
Europe
ABNCoV2
Bavarian Nordic
COVID-19 Disease
12/21
02/24
ES2B-C001 / ExpreS2ion
No trials found

Download Options